In the News

Insulin prices drop, may spur long-term trend

A major manufacturer announced a cut in the prices of its insulins and instituted a $35 out-of-pocket monthly cap for commercially insured patients.

Overnight glucose associated with next-day functioning in adults with type 1 diabetes

More variation in overnight glucose levels and time spent above and below glucose targets were associated with adverse changes in measures of next-day function, including attention, sedentary time, and engagement in demanding activities, a study found.

Social, medical intervention improved glycemic control in rural patients with diabetes

A population health team assessed patients' medical, behavioral, and social needs with annual health risk assessments and partnered with community organizations to improve their access to food, transportation, and medicine.

MKSAP quiz: Nausea, vomiting, malaise in a patient with type 2 diabetes

This month's quiz asks readers to diagnose a 58-year-old woman with type 2 diabetes mellitus who is seen in the emergency department for nausea, vomiting, and malaise.

Spotlight on prescribing patterns

One study found that physicians were unlikely to deprescribe hypoglycemia-causing medications in older diabetes patients, while others found suboptimal use of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and additional recommended medications.

Annals On Call: First-line drug therapy for type 2 diabetes

Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode covered a study of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists as first-line therapy.

ACP Journal Club: SGLT-2 inhibitors reduce adverse renal and CV outcomes in patients with or without diabetes

The results of this meta-analysis of sodium-glucose cotransporter-2 (SGLT-2) inhibitors highlight the opportunity for internists, nephrologists, endocrinologists, and cardiologists to collaborate to expand use of the drug class, an ACP Journal Club commentary said.

Getting to know GLP-1 receptor agonists

The latest Pearls from I.M. Peers offers advice on prescribing glucagon-like peptide-1 (GLP-1) receptor agonists for patients with diabetes.

Overweight, obesity poorly managed in type 1 diabetes

While U.S. adults with type 1 diabetes have rates of overweight and obesity virtually identical to those in the general adult population, only about 50% received lifestyle recommendations for weight management from clinicians or tried lifestyle modifications.